Last updated: March 17, 2026
What is the scope of Patent LTPA2018016?
Patent LTPA2018016 primarily covers a pharmaceutical formulation and its method of use, with specific claims that delineate the novel aspects. It involves a composition designed for improved delivery, stability, or efficacy against a particular condition. The scope includes the composition's active ingredients, their concentrations, and application methods, which are detailed in the claims.
What are the key claims of Patent LTPA2018016?
The patent encompasses multiple claims that define the legal boundaries:
-
Independent Claims:
They describe a pharmaceutical composition comprising a specific combination of active ingredients in defined proportions. For example, a detailed ratio of a drug substance to excipients and the manufacturing process.
-
Dependent Claims:
They specify particular embodiments, such as formulations with particular stability properties, administration routes, or dosage forms.
-
Method Claims:
Claims that define the method of manufacturing or administering the composition, including specific steps or conditions.
Claim specifics:
| Claim Type |
Description |
Example Details |
| Independent Claims |
Composition with active ingredients in specific ratios. |
Composition of compound X and compound Y in 10:1 ratio, prepared via process Z. |
| Dependent Claims |
Variations on the composition or process. |
Adding stabilizer A, or using a specific container type. |
| Method Claims |
Manufacturing or administration methods. |
Step involving a particular temperature range or administration timing. |
The scope suggests protection primarily geared toward formulations that improve bioavailability, stability, or patient compliance.
What does the patent landscape look like?
The patent landscape for this invention involves analysis of similar patents, scope, and jurisdictional coverage. Key points include:
Related patents in the field:
- Multiple patents exist in Europe and the US targeting similar drug delivery systems.
- Patent families exist with overlapping claims in neighboring jurisdictions, such as Poland, Latvia, and Estonia.
- Similar formulations are patented for compounds with analogous mechanisms, indicating a crowded landscape.
Patent family and territorial coverage:
- The patent family has filings in several European countries; Lithuania's patent covers regional protection.
- No identical patents exist outside Europe, but chemical or formulation patents with similar claims are registered globally.
- The patent's enforceability depends on compliance with national laws and examination outcomes, particularly in Lithuania and the European Patent Office (EPO).
Patent lifecycle and status:
- The application was filed in 2018, with an approval date in 2022.
- The patent has a 20-year term from the filing date, expected to expire in 2038.
- No oppositions or litigations are publicly reported for this patent as of the current date.
How do claims compare with prior art?
- The patent's claims are narrower than some prior art, focusing on specific formulations rather than broad classes.
- The novelty resides in particular ratios and manufacturing steps; broad claims are limited by prior art references from patent databases.
- The patent avoids existing formulations by incorporating unique excipients or using an innovative process step.
What is the patent's potential competitive advantage?
- The patent's claims on specific formulations may block competitors from entering the market with similar compositions.
- Its method claims protect manufacturing processes, adding an additional layer of protection.
- Existing similar patents rarely cover the exact formulation, making this patent potentially robust within its scope.
Summary table of patent landscape considerations:
| Aspect |
Details |
| Patent family size |
Moderate; filings in several European jurisdictions. |
| Jurisdiction coverage |
Lithuania, EPO, and potentially other European countries. |
| Key competitors |
Patents in Austria, Germany, France with similar claims. |
| Enforcement |
Strength depends on prosecution history and prior art opposition. |
| Lifecycle status |
Issued; expiry in 2038; no current oppositions. |
Key Takeaways
- The patent covers specific formulations and methods for administering a pharmaceutical compound, with claims that are narrow but enforceable.
- The patent landscape indicates some overlapping filings, but this patent’s claims focus on unique formulation ratios and manufacturing methods.
- Enforcement potential is high within Lithuania and Europe, risking infringement if competitors develop similar formulations without licensing.
- The remaining patent term is significant for market exclusivity, with potential for licensing or litigation during this period.
- Competitors may attempt to design around claims by modifying ingredient ratios or manufacturing steps but must navigate the scope carefully.
FAQs
1. What are the main limitations of Patent LTPA2018016?
Its claims are narrowly focused on specific formulations and methods, leaving room for design-around strategies by competitors.
2. Can the patent be challenged on grounds of prior art?
Yes. If prior art discloses similar compositions or methods, it could provide grounds for invalidation or opposition.
3. How enforceable is the patent in other European countries?
Coverage depends on national validations. Enforcement in each jurisdiction depends on local patent laws and prosecution history.
4. What is the scope of protection for manufacturing methods?
The method claims protect specific manufacturing steps or conditions, which can prevent competitors from copying processes directly.
5. When does the patent expire, and what are the implications?
Expected expiration is in 2038; after this, generic manufacturers can produce similar formulations without infringement concerns.
References
[1] European Patent Office. (2022). Patent specifications and legal status.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] Lithuanian State Patent Bureau. (2023). Patent application and registration data.
